OHSU Knight Cancer Institute Research Groups:OCI Research Group Meetings
Home Faculty Graduate Program Postdocs OHSU Knight Core Facilities
Programs
Res Group Meetings
Cancer Journal Club
Cell/CANB 616
Gen. Inst/R3 Club
CANB 610
Objectives of the OHSU Knight Cancer Biology Research Group Meetings
Cross-departmental workshop composed of students, postdocs, and faculty with shared interest in basic principles and emerging discoveries in Cancer Biology. The goals of the meetings and this wiki:
- Establish a challenging and interactive cross-departmental focus group that will advance understanding of our individual projects and encourage collaborations.
- Provide students and postdocs with training and interactions with faculty interested in Cancer Biology and emerging therapeutics
These meetings are now expanded to include a Translational Cancer Research Group Meeting. The purpose of this meeting is to:
- Serve to foster a Knight translational research incubator for projects and teams leading to multi-investigator cancer program/SPORE funding including the Solid tumors and Hematologic Malignancies programs and the Systems Biology group.
- Meetings will include thematic research and clinical research talks with collaborative and developmental potential and Brainstorming Sessions.
Knight Research Group Activities
Want to join us? All are invited!
- To get on the listserve:
- go to the following web site:
- http://mailman.ohsu.edu/cgi-bin/mailman/listinfo/oncres
- follow the instructions for subscribing
- We meet in the Knight Conference Room 14th floor Hatfield Research Bldg
- Fridays 9:15-10:15 AM - see schedule below
- Breakfast provided by the Knight!
- Organizer: Rosie Sears, email searsrATohsu.edu
Member Labs and Affiliations
Lopez Lab Hem Onc
Sears Lab, MMG
Hoatlin Lab, BMB
Thayer Lab, BMB
Lloyd Lab, CROET
McCullough Lab, CROET
Wong Lab, Dermatology, CDB
Zundel Lab, Radiation Medicine, Cancer Biology
Spindel Lab, Primate Center, NGP, Cancer Biology
- Add your lab here
Schedule
*Red indicates Translational Cancer Research Group Meetings
Date | Presenters | Topic | Links & Comments | Location |
9/23/2011 | Thomas Jacob | Fluorescent quantum dot nanoparticle technology for molecular assessment of oncogenic kinase signaling | Dr. Tania Vu’s lab in biomedical engineering | |
10/7/2011 | Brett Sheppard | Pancreatic Cancer- Setting the Stage | ||
10/14/2011 | Eliot Spindel | Targeting cholinergic signaling in lung cancer | Dr. Eliot Spindel's lab: Neuroscience meets lung cancer and lung development | |
10/21/2011 | Soren Impey | Pancreas | ||
10/28/2011 | ||||
11/4/2011 | Philip Streeter | Pancreas: Immunoassays for Detection of Early Pancreatic Cancer | ||
11/11/2011 | Joe Gray | Pancreas: “Subtyping pancreatic cancers – advancing diagnosis and treatment” | ||
11/18/2011 | Fox Lab | Pancreas | ||
12/2/2011 | Rosie Sears | Pancreas: | ||
12/9/2011 | Charles Springer | Can MRI Map the Angiogenic Switch in Human Breast Tumors in Vivo? | ||
12/16/2011 | Pancreas: Brain Storming | |||
1/6/2012 | CANCELLED | |||
1/13/2012 |
Steve Chui Shiuh-Wen Luoh |
Breast Cancer: I-Spy-2 and tissue collection | ||
1/20/2012 |
Megan Troxell |
Breast Cancer: Pathologist PI3K mutations in early breast cancer lesions | ||
1/27/2012 | Joshi Alumkal | Thinking Outside the (Androgen) Box in Prostate Cancer | ||
2/3/2012 |
Rosie Sears Jim Korkola |
Breast Cancer: Korkola: Combination Therapies and Irreversible Inhibitors for the treatment of HER2 positive breast cancer; Sears: Strategies to target c-Myc in breast cancer | ||
2/10/2012 | Steven Jacques | Label-free optical imaging of cellular processes | ||
2/17/2012 |
Lisa Coussens |
Breast Cancer:Inflammation and Breast Cancer: Targeting Macrophages to Enhance Chemotherapy | ||
2/24/2012 | George Thomas | Re-thinking Targeted Therapies for Kidney Cancer | ||
3/2/2012 | Juha Rantala
Koei Chin |
Breast Cancer (Rantala): Targeted RNAi screens in breast cancer cells using cell spot microarrays.
Breast Cancer (Chin): Omics Analysis in Breast Cancer: Genome to Protein |
||
3/9/2012 | Daniel Marks | Brain Mechanisms in Cancer Cachexia | ||
3/16/2012 | Xiangshu Xiao | Breast Cancer: Small Molecules Targeting CREB for Breast Cancer Therapy | ||
3/23/2012 | Canceled for the 2012 BioMedicine in 4D Conference | [1] | ||
3/30/2012 | NO MEETING | Spring Break | ||
4/6/2012 | Allen Ebens, PhD | The role of PI3 and PIM kinases in multiple myeloma | ***Note the location change *** | MAC HALL 2201 |
4/13/2012 | Jen Vomaske | CXCR7-mediated Endothelial Dysfunction: Implications for Tumor Vascular Normalization | ***Note the location change *** | MAC HALL 2201 |
4/20/2012 | Zhi Hu
Wassana Yantasee |
Part I. Optimization of therapeutic siRNA against HER2 (Hu)
Part II. Nanoparticle platform for siRNA delivery and HER2 silencing (Yantasee) |
***Note the location change *** | MAC HALL 2201 |
4/27/2012 | Lucia Carbone | Mechanisms of chromosomal rearrangement in evolution and cancer | ***Note the location change *** | MAC HALL 2201 |
5/4/2012 | Joe Gray
Paul Spellman |
Breast Cancer: Prospects for interrogating the signaling nanostructure of breast cancer
Breast Cancer:Genomic Analysis of Breast Cancers. Beyond TCGA |
***Note the location change *** | MAC HALL 2201 |
5/11/2012 | Wong Lab (Nick Smith, Emily Bubbers) | ***Note the location change *** | MAC HALL 2201 | |
5/18/2012 | John Muschler
Sunjong Kwon |
Breast Cancer
Sunjong Kwon: Quantitative Imaging of individual mRNAs and co-staining of protein in breast cancer cells |
***Note the location change *** | MAC HALL 2201 |
5/25/2012 | Brainstorming - Breast Cancer Focus | ***Note the location change *** | MAC HALL 2201 | |
6/8/2012 | Kinrin Yamanaka (Dr. Stephen Lloyd lab) | Molecular Targeting of Translesion Synthesis DNA Polymerases for Novel Combination Chemotherapy | ***Note the location change *** | MAC HALL 2201 |
6/15/2012 | Liskay Lab | Inhibiting occult clonal expansion of mutant cells as a mechanism of chemoprevention | ***Note the location change *** | MAC HALL 2201 |
6/22/2012 | Neil Osheroff | Vanderbilt | ***Note the location change *** | MAC HALL 2201 |